Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Alaunos Therapeutics

Explore full profile

Formerly ZIOPHARM Oncology, developing novel therapeutics for the treatment of cancer

Fort Lauderdale, United StatesFounded 2005Biotech & Life Sciences
Valuation $18M Market cap · 2024
Revenue $5K Latest reported FY

About Alaunos Therapeutics

Ziopharm Oncology is a biotechnology company focused on developing advanced gene and cell therapies to combat cancer. Operating in the immuno-oncology sector, Ziopharm serves patients with blood cancers and solid tumors. The company leverages its proprietary technologies, such as the Sleeping Beauty non-viral genetic modification platform, to create CAR T cells and TCRs that can be rapidly and cost-effectively manufactured. Ziopharm's business model revolves around the development and clinical trials of these therapies, aiming to bring them to market for widespread medical use. Revenue is generated through partnerships, licensing agreements, and eventual commercialization of their therapies. The company is currently in various phases of clinical trials, including Phase 1 trials for their Rapid Personalized Manufacturing (RPM) CAR T technology targeting relapsed CD19 leukemias and lymphomas. Ziopharm's mission is to harness the power of the immune system to provide innovative treatment options for cancer patients.

Source: Dealroom company data

At a glance

Status
Listed
Founded
2005
Headquarters
Fort Lauderdale, United States
Listing
IPO 2005
Sector
Biotech & Life Sciences

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later6 investors entered at this stage

  • ProQuest Investments
  • Cycad Group
  • Paramount BioCapital Asset Management
  • LBI Group
  • Pangaea Asset Management
  • Emerging Technology Partners Biomedical

Talent

Book a demo to see the people
Team profiled 8 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Fort Lauderdale HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Alaunos Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Alaunos Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles